248 related articles for article (PubMed ID: 28815274)
1. A new metabolomics-based strategy for identification of endogenous markers of urine adulteration attempts exemplified for potassium nitrite.
Steuer AE; Arnold K; Schneider TD; Poetzsch M; Kraemer T
Anal Bioanal Chem; 2017 Oct; 409(26):6235-6244. PubMed ID: 28815274
[TBL] [Abstract][Full Text] [Related]
2. Suitability evaluation of new endogenous biomarkers for the identification of nitrite-based urine adulteration in mass spectrometry methods.
Steuer AE; Arnold K; Kamber D; Kraemer T
Drug Test Anal; 2019 Feb; 11(2):230-239. PubMed ID: 30118186
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of endogenous urinary biomarkers for indirect detection of urine adulteration attempts by five different chemical adulterants in mass spectrometry methods.
Steuer AE; Kamber D; Kraemer T
Drug Test Anal; 2019 May; 11(5):638-648. PubMed ID: 30408836
[TBL] [Abstract][Full Text] [Related]
4. Urinary exposure marker discovery for toxicants using ultra-high pressure liquid chromatography coupled with Orbitrap high resolution mass spectrometry and three untargeted metabolomics approaches.
Hsu JY; Hsu JF; Chen YR; Shih CL; Hsu YS; Chen YJ; Tsai SH; Liao PC
Anal Chim Acta; 2016 Oct; 939():73-83. PubMed ID: 27639145
[TBL] [Abstract][Full Text] [Related]
5. Adulterants in Urine Drug Testing.
Fu S
Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
[TBL] [Abstract][Full Text] [Related]
6. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
[TBL] [Abstract][Full Text] [Related]
7. Systematic investigations of novel validity parameters in urine drug testing and prevalence of urine adulteration in a two-year cohort.
Kluge J; Rentzsch L; Remane D; Peters FT; Wissenbach DK
Drug Test Anal; 2018 Oct; 10(10):1536-1542. PubMed ID: 29956490
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
9. Identification of new urinary gamma-hydroxybutyric acid markers applying untargeted metabolomics analysis following placebo-controlled administration to humans.
Steuer AE; Raeber J; Steuer C; Boxler MI; Dornbierer DA; Bosch OG; Quednow BB; Seifritz E; Kraemer T
Drug Test Anal; 2019 Jun; 11(6):813-823. PubMed ID: 30548573
[TBL] [Abstract][Full Text] [Related]
10. A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine.
Sundström M; Pelander A; Angerer V; Hutter M; Kneisel S; Ojanperä I
Anal Bioanal Chem; 2013 Oct; 405(26):8463-74. PubMed ID: 23954996
[TBL] [Abstract][Full Text] [Related]
11. Detection and identification of 2-nitro-morphine and 2-nitro-morphine-6-glucuronide in nitrite adulterated urine specimens containing morphine and its glucuronides.
Luong S; Fu S
Drug Test Anal; 2014 Mar; 6(3):277-87. PubMed ID: 23592389
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dilution and normalization strategies to correct for urinary output in HPLC-HRTOFMS metabolomics.
Vogl FC; Mehrl S; Heizinger L; Schlecht I; Zacharias HU; Ellmann L; Nürnberger N; Gronwald W; Leitzmann MF; Rossert J; Eckardt KU; Dettmer K; Oefner PJ;
Anal Bioanal Chem; 2016 Nov; 408(29):8483-8493. PubMed ID: 27815612
[TBL] [Abstract][Full Text] [Related]
13. Rapid spot tests for detecting the presence of adulterants in urine specimens submitted for drug testing.
Dasgupta A; Wahed A; Wells A
Am J Clin Pathol; 2002 Feb; 117(2):325-9. PubMed ID: 11863230
[TBL] [Abstract][Full Text] [Related]
14. Identification of adulteration in botanical samples with untargeted metabolomics.
Wallace ED; Todd DA; Harnly JM; Cech NB; Kellogg JJ
Anal Bioanal Chem; 2020 Jul; 412(18):4273-4286. PubMed ID: 32347364
[TBL] [Abstract][Full Text] [Related]
15. The measurement of nitrite in adulterated urine samples by high-performance ion chromatography.
Singh J; Elberling JA; Hemphill DG; Holmstrom J
J Anal Toxicol; 1999; 23(3):137-40. PubMed ID: 10369320
[TBL] [Abstract][Full Text] [Related]
16. Assessment of fruit juice authenticity using UPLC-QToF MS: a metabolomics approach.
Jandrić Z; Roberts D; Rathor MN; Abrahim A; Islam M; Cannavan A
Food Chem; 2014 Apr; 148():7-17. PubMed ID: 24262519
[TBL] [Abstract][Full Text] [Related]
17. A short review of applications of liquid chromatography mass spectrometry based metabolomics techniques to the analysis of human urine.
Zhang T; Watson DG
Analyst; 2015 May; 140(9):2907-15. PubMed ID: 25756251
[TBL] [Abstract][Full Text] [Related]
18. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
Sundström M; Pelander A; Ojanperä I
Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
[TBL] [Abstract][Full Text] [Related]
19. False-negative results in the immunoassay analysis of drugs of abuse: can adulterants be detected by sample check test?
Matriciani B; Huppertz B; Keller R; Weiskirchen R
Ann Clin Biochem; 2018 May; 55(3):348-354. PubMed ID: 28728424
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry.
Saleh A; Stephanson NN; Granelli I; Villén T; Beck O
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():6-13. PubMed ID: 23153637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
